Copies to: |
Mark V. Roeder, Esq. Brian J. Cuneo, Esq. Latham & Watkins LLP 140 Scott Drive Menlo Park, CA 94025 (650) 328-4600 |
o Large accelerated Filer | o Accelerated Filer | |
x Non-accelerated Filer | o Smaller Reporting Company | |
(Do not check if a smaller reporting company) |
Title of Securities To Be Registered | Amount To Be Registered(1) | Proposed Maximum Offering Price Per Share(2) | Proposed Maximum Aggregate Offering Price(2) | Amount of Registration Fee | ||||
Common Stock, $0.001 par value per share | 1,545,356 shares | $10.27 | $15,870,806.12 | $1,844.19 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (this “Registration Statement”) shall also cover any additional shares of the Registrant’s common stock that become issuable under the 2014 Employment Commencement Incentive Plan (the “Inducement Plan”), the 2014 Equity Incentive Award Plan (the “2014 Plan”) and the 2014 Employee Stock Purchase Plan (the “ESPP”), by reason of any stock dividend, stock split, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding shares of common stock. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering price for shares reserved for future issuance under the Inducement Plan, the 2014 Plan and the ESPP are based on the average of the high and the low price of Registrant’s common stock as reported on The NASDAQ Global Market on March 9, 2015. The chart below details the calculations of the registration fee: |
Securities | Number of Shares | Offering Price Per Share | Aggregate Offering Price |
Shares available for future grant under the 2014 Plan(3) | 716,285 | $10.27(2) | $7,356,246.95 |
Shares available for future grant under the ESPP(4) | 179,071 | $10.27(2) | $1,839,059.17 |
Shares available for future grant under the Inducement Plan | 650,000 | $10.27(2) | $6,675,500.00 |
Proposed Maximum Aggregate Offering Price | $15,870,806.12 | ||
Registration Fee | $1,844.19 |
(3) | Represents the additional shares of common stock available for future issuance under the Registrant’s 2014 Plan resulting from an annual increase as of January 1, 2015. |
(4) | Represents the additional shares of common stock available for future issuance under the Registrant’s ESPP resulting from an annual increase as of January 1, 2015. |
(a) | The Annual Report on Form 10-K for the year ended December 31, 2014, filed by the Registrant with the Commission on March 16, 2015 (File No. 001-36323); |
(b) | The Current Report on Form 8-K filed by the Registrant with the Commission on March 12, 2015 (File No. 001-36323); and |
(c) | The description of the Registrant’s common stock contained in the Registrant’s registration statement on Form 8-A (File No. 001-36323), filed by the Registrant with the Commission under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on February 25, 2014, including any amendments or reports filed for the purpose of updating such description. |
• | any breach of the director’s duty of loyalty to the Registrant or its stockholders; |
• | any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or |
• | any transaction from which the director derived an improper personal benefit. |
• | the Registrant will indemnify its directors and officers, and may indemnify its employees and agents, to the fullest extent permitted by the General Corporation Law of the State of Delaware, subject to limited exceptions; |
• | the Registrant will advance expenses to its directors and officers, and may advance expenses to its employees or agents, in connection with a legal proceeding to the fullest extent permitted by the General Corporation Law of the State of Delaware, subject to limited exceptions; and |
• | the rights provided in the amended and restated bylaws are not exclusive. |
1. | The undersigned Registrant hereby undertakes: |
a. | To file, during any period in which offers or sales are being made pursuant to this Registration Statement, a post-effective amendment to this Registration Statement: |
b. | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
c. | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
2. | The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
3. | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described under “Item 6-Indemnification of Directors and Officers,” or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
Achaogen, Inc. | |
By: /s/ Kenneth J. Hillan Name: Kenneth J. Hillan, M.B., Ch.B. Title: President & Chief Executive Officer |
Signature | Title | Date | ||
/s/ Kenneth J. Hillan | President, Chief Executive Officer and Director | March 16, 2015 | ||
Kenneth J. Hillan, M.B., Ch.B. | (Principal Executive Officer) | |||
/s/ Derek A. Bertocci | Senior Vice President and Chief Financial Officer | March 16, 2015 | ||
Derek A. Bertocci | (Principal Financial and Accounting Officer) | |||
/s/ Bryan E. Roberts | Chairman of the Board | March 16, 2015 | ||
Bryan E. Roberts, Ph.D. | ||||
/s/ Christopher S. Boerner | Director | March 16, 2015 | ||
Christopher S. Boerner, Ph.D. | ||||
/s/ Scott M. Rocklage | Director | March 16, 2015 | ||
Scott M. Rocklage, Ph.D. | ||||
/s/ Camille D. Samuels | Director | March 16, 2015 | ||
Camille D. Samuels | ||||
/s/ Alan B. Colowick | Director | March 16, 2015 | ||
Alan B. Colowick, M.P.H., M.D. | ||||
/s/ John C. Doyle | Director | March 16, 2015 | ||
John C. Doyle | ||||
/s/ Kent E. Lieginger | Director | March 16, 2015 | ||
Kent E. Lieginger, Pharm.D. | ||||
/s/ John W. Smither | Director | March 16, 2015 | ||
John W. Smither | ||||
/s/ Christopher T. Walsh | Director | March 16, 2015 | ||
Christopher T. Walsh, Ph.D. |
Incorporated by Reference from | Provided Herewith | |||||||||||
Exhibit Number | Description of Document | Registrant's Form | File No. | Date Filed with the Commission | Exhibit Number | |||||||
4.1 | Amended and Restated Certificate of Incorporation of Achaogen, Inc. | 8-K | 001-36323 | 3/17/2014 | 3.1 | |||||||
4.2 | Amended and Restated Bylaws of Achaogen, Inc. | 8-K | 001-36323 | 3/17/2014 | 3.2 | |||||||
4.3 | Form of Common Stock Certificate | S-1/A | 333-193559 | 2/25/2014 | 4.1 | |||||||
4.4 | Warrant issued to Oxford Finance LLC on November 1, 2011. | S-1 | 333-193559 | 1/24/2014 | 4.4 | |||||||
4.5 | Warrant issued to Silicon Valley Bank on November 1, 2011. | S-1 | 333-193559 | 1/24/2014 | 4.5 | |||||||
4.6 | Warrant issued to Oxford Finance LLC on April 30, 2012 (Term A Loan (2)). | S-1 | 333-193559 | 1/24/2014 | 4.6 | |||||||
4.7 | Warrant issued to Oxford Finance LLC on April 30, 2012 (Term B Loan). | S-1 | 333-193559 | 1/24/2014 | 4.7 | |||||||
5.1 | Opinion of Latham & Watkins LLP. | X | ||||||||||
23.1 | Consent of Independent Registered Public Accounting Firm. | X | ||||||||||
23.2 | Consent of Latham & Watkins LLP (included in Exhibit 5.1). | X | ||||||||||
24.1 | Power of Attorney (included on signature page hereto). | X | ||||||||||
99.1(A) | Achaogen, Inc. 2014 Equity Incentive Award Plan. | S-8 | 333-195348 | 4/17/2014 | 99.3 | |||||||
99.1(B) | Form of Stock Option Agreement under the Achaogen, Inc. 2014 Equity Incentive Award Plan. | S-1/A | 333-193559 | 2/12/2014 | 10.2(B) | |||||||
99.1(C) | Form of Restricted Stock Award Agreement under the Achaogen, Inc. 2014 Equity Incentive Award Plan. | S-1/A | 333-193559 | 2/12/2014 | 10.2(C) | |||||||
99.1(D) | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Achaogen, Inc. 2014 Equity Incentive Award Plan. | 10-K | 001-36323 | 3/16/2015 | 10.9(D) | |||||||
99.2 | Achaogen, Inc. 2014 Employee Stock Purchase Plan. | S-8 | 333-195348 | 4/17/2014 | 99.7 | |||||||
99.3(A) | Achaogen, Inc. 2014 Employment Commencement Incentive Plan. | 10-K | 001-36323 | 3/16/2015 | 10.11(A) | |||||||
99.3(B) | Form of Stock Option Grant Notice and Stock Option Agreement under the Achaogen, Inc. 2014 Employment Commencement Incentive Plan. | 10-K | 001-36323 | 3/16/2015 | 10.11(B) | |||||||
99.3(C) | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Achaogen, Inc. 2014 Employment Commencement Incentive Plan. | 10-K | 001-36323 | 3/16/2015 | 10.11(C) |